CervoMed's neflamapimod receives UK innovation passport for DLB

Go back to CervoMed's neflamapimod receives UK innovation passport for DLB
(NASDAQ: CRVO) Delayed: 2.86 --0 (-0%)
Previous Close $2.86    52 Week High
Open $2.86    52 Week Low
Day High $2.86    P/E N/A 
Day Low $2.86    EPS
Volume 5,706